Recent Updates
Recently added Catalysts
BVS Negative Sentiment Score: 20/100

Bioventus Inc Investors: Please contact the Portnoy Law Firm to recover your losses

Key Takeaway: Bioventus Inc (NASDAQ: BVS) is facing an investigation initiated by the Portnoy Law Firm on behalf of investors who have incurred losses. Concerns have been raised regarding the company’s financial stability, stemming from issues with a contested invoice and inadequate internal controls over quarterly financial reporting. The stock experienced a significant decline following these revelations. Investors are encouraged to contact the law firm for a complimentary case evaluation and to discuss potential legal actions.

Market Sentiment Analysis

CONCERNS & RISKS

  • Bioventus Inc is under investigation for potential losses suffered by investors.
  • The company faced issues with an invoice from a major payer affecting financial reporting.
  • Management has acknowledged inadequate internal controls related to quarterly rebates.
  • There are concerns about the company's ability to meet financial obligations in the coming year.

Full Press Release Details

Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, March 09, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Bioventus Inc (“Bioventus”) (NASDAQ: BVS) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Bioventus stock. Bioventus investors are encouraged to contact the firm to discuss their legal rights.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
On November 17, 2022, Bioventus filed for an extension to publish its quarterly report due to a contested invoice from a large private payer in the company’s pain treatments vertical, “which likely will adversely affect the company’s third quarter 2022 financial results.” Bioventus further disclosed that “management has concluded that its internal controls related to the timely recognition of quarterly rebates were inadequate.” The company also announced that is also evaluating whether it “will be able to meet all of its financial obligations as they come due within one year after the date its financial statements for the period ended October 1, 2022 are issued.”
On this news, Bioventus stock fell sharply during after-hours trading on November 17, 2022.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
Attorney Advertising

Tags

Frequently Asked Questions

How can Bioventus investors contact the law firm?

Bioventus investors can reach the Portnoy Law Firm at 844-767-8529 or via email at lesley@portnoylaw.com.

What prompted the investigation into Bioventus Inc?

The investigation was initiated due to significant losses investors suffered related to Bioventus stock.

Is there a cost for investors to contact the law firm?

No, contacting the Portnoy Law Firm to discuss recovery options is free of charge.

What financial issues did Bioventus disclose?

Bioventus reported inadequate internal controls and questioned its ability to meet financial obligations.

What was the impact of Bioventus's news on its stock?

Following the news on November 17, 2022, Bioventus stock experienced a sharp decline in after-hours trading.

Last updated: Mar 10, 2023